Press Release Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights Aug 4
Press Release Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors Jul 23